A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer

NCT00548548 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

774

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenocarcinoma

Interventions

DRUG: Bevacizumab
DRUG: Capecitabine
DRUG: Cisplatin
DRUG: Placebo
DRUG: 5-fluorouracil

Sponsor

Genentech, Inc.

Collaborators

[object Object]
[object Object]